# Prospan® Hustenzäpfchen - Investigation on Efficacy and Tolerability in Children

> **NCT01127048** · PHASE3 · UNKNOWN · sponsor: **Engelhard Arzneimittel GmbH & Co.KG** · enrollment: 1400 (estimated)

## Conditions studied

- Symptoms of Acute Bronchitis Accompanied by Coughing

## Interventions

- **DRUG:** Suppositories containing Ivy leaves dry extract
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01127048
- **Lead sponsor:** Engelhard Arzneimittel GmbH & Co.KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2011-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01127048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01127048, "Prospan® Hustenzäpfchen - Investigation on Efficacy and Tolerability in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01127048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*